Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23ClFN3O2 |
InChIKeyKVXKOOFISWGJCJ-VNRZBHCFSA-N |
CAS Registry1009080-74-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | Australia | 01 Jul 2008 |